They posted record revenue and 'tight' capacity, yet Q4 margin guidance relies on a $30M asset sale to stay flat.
Thesis: Amkor is a classic 'profitless prosperity' trap. They are the bottleneck remover for TSMC but lack the leverage to charge for it. Despite 'tightness of supply' in advanced packaging, gross margins are compressing YoY when stripping out one-time asset sales. The $7B Arizona commitment locks them into a massive CapEx cycle ($950M in 2025 alone) with no revenue payoff until 2028. You are buying a capital-intensive utility, not a technology compounder.
Verdict: AVOID — Conviction: MEDIUM
Catalyst: Q4 earnings release, specifically the ex-items gross margin. If it drops below 14% without the asset sale, the 'margin expansion' narrative breaks.
Key Risk: The 'High-Density Fan-Out' ramp accelerates faster than expected, driving mix-shift margin improvement before the Arizona depreciation hits.
The Tell: The CFO's admission on Q4 guidance: 'Gross margin is projected to be between 14% and 15%, which includes an anticipated benefit from asset sales of around $30 million.' Strip that out, and margins are deteriorating sequentially despite record revenue.
Friction Level: HIGH_FRICTION — Bulls see the $7B Arizona build as a growth engine; Bears see it as a depreciation anchor. The disagreement is whether capacity equals profit.
Report not found
The report data is no longer available. Please return to the archive.